INDIANAPOLIS – Beckman Coulter Life Sciences today announced it has entered into an application development agreement with Invitae (NYSE: NVTA), a leading medical genetics company, to enable the development of new applications on its newest NGS automation platform, the Biomek NGeniuS Next Generation Library Prep System. The Biomek NGeniuS Liquid Handling System* is a purpose-built liquid […]

[Ames, Iowa ]  Skroot Laboratory, Inc. has joined the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT). CMaT is a consortium of universities, companies, and clinical collaborators brought together to develop transformative tools and technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. The center, launched in […]

SINFONIA TECHNOLOGY CO., LTD. (Head office: Minato-ku, Tokyo; President: Fuminori Saito) has been developing a fully automated cell culture instrument in collaboration with the Foundation for Biomedical Research and Innovation at Kobe (FBRI; Locations: Kobe City, Hyogo Prefect.; President: Tasuku Honjo, M.D.,Ph.D.). With the successful results of demonstration experiments with human iPS cells and mesenchymal […]

The start up Celtarys Research, born at the University of Santiago de Compostela and dedicated to the development of fluorescent tools for drug discovery, has closed a seed capital investment round of 650,000 euros. In the round have participated the Galician institutional funds of the Xunta de Galicia – through XesGalicia – and VigoActivo, as […]

DUBAI – NanoCellect Biomedical Inc. a privately-held life sciences company, focused on developing microfluidic based cell analysis and sorting solutions, has signed an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka. Dr. Will Alaynick, Co-founder and Vice President International at NanoCellect […]

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays. Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a […]

CAMBRIDGE, MA—Draper has received a $719,000 federal contract from the U.S. Department of Health and Human Services (HHS) to enhance the company’s tissue-chip platform for advanced studies of viral infection. With the contract, Draper will design a model for human airway tissue and adapt its PREDICT96 platform to collect data for SARS-CoV-2 infection studies. The […]

The Oxford Nanopore “Q20+” kit is now available to any Oxford Nanopore user who registers their interest. As part of this Early Access programme, Oxford Nanopore will make available its latest flow cell chemistry, “R10.4” for first user trials. First announced at the London Calling conference in May 2021, the Q20+ chemistry enables users to generate […]

AMSBIO has further expanded its product range to help in the fight against COVID-19 with the introduction of a new range of aptamers targeting SARS-CoV-2 proteins to aid development of new kits and assays. Aptamers are small single-stranded RNA or DNA oligonucleotides that fold in a three-dimensional conformation allowing them to bind specifically to a […]

SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with deepCDR, a private company focused on applying deep learning algorithms to antibody discovery and optimization. “We continue to leverage and integrate cutting-edge technologies […]